Leveraging powerful genomics tools, researchers have learned much about the genetic alterations associated with various types of cancer. In some cases, this has led to the successful development of precision medicines targeting cancer, but these are effective for just a subset of patients. Building on genomics studies and leveraging proteomics tools, researchers have revealed that proteins and protein networks drive cancer biology in ways that are not obvious from genomic mutations alone. Watch the full animation or jump to the chapters listed below to learn how proteomics can:
- Chapter 1 (01:26) – Show how cancers become resistant to therapy
- Chapter 2 (02:14) – Detect how non-malignant cells impact cancer progression
- Chapter 3 (02:57) – Assess determinants of response to precision medicines
For more information and in-depth examples of the power of proteomics in cancer research, check out our Proteomics and cancer eBook.
MORE ARTICLES